Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,648   7.83  Index Moved Down -0.47%
ABT MDT SYK ISRG Conglomerates Music and Video Soft Drinks Air 
United States GSPC USD ...  |  Company Directory


Processing
Processing. Please wait...

St Jude insider: Stuart Essig

       

Stuart Essig - St Jude Insider Profile

Independent Director

Mr. Stuart M. Essig is Independent Director of St. Jude Medical Inc., since 1999. Mr. Essig is currently the Chairman of the Board of Directors of Integra LifeSciences Holdings Corporationrationration, a manufacturer of medical devices and implants, a position he has held since January 2012. Prior to such role, Mr. Essig served as Integra?s Chief Executive Officer from December 1997 until January 2012 and its President from December 1997 until November 2010. In addition, he has served as a director since he joined Integra in December 1997. Prior to joining Integra, Mr. Essig supervised the medical technology practice at Goldman, Sachs & Co. as a managing director. Mr. Essig has also served on the Board of Directors of the Advanced Medical Technology Association, a trade association that represents the medical device industry.
Age: 50  Director Since 1999      
651-756-2000  http://www.sjm.com

Other Appointments

Integra LifeSciences Holdings CIARTUnited States Nasdaq
Chairman since 2012

Management Efficency

The company has Return on Asset of 10.02 % which means that on every $100 spent on asset it made $10.02 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.48 % implying that it generated $18.48 on every 100 dollars invested.
The company has 3.36 B in debt with debt to equity (D/E) ratio of 0.88 which is OK given its current industry classification. St Jude Medical Inc has Current Ratio of 2.05 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
    

Other Executives

Daniel Starks, Chairman
Jason Zellers, President
Jane Song, President
Thomas Northenscold, President
Jeff Fecho, President
Angela Craig, President
Kathleen Chester, President
Frank Callaghan, President
Rachel Ellingson, President, MBA
Eric Fain, President
Rohan Hoare, President
Joel Becker, President
Denis Gestin, President
Donald Zurbay, CFO
John Heinmiller, EVP, CPA
Michael Rocca, Director
Wendy Yarno, Director
Thomas Garrett, Director
Barbara Hill, Director
Richard Devenuti, Director
John Brown, Director
Eric MD, Executive
J Weigelt, Executive
Michael Rousseau, Executive

Entity Summary

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. St Jude Medical Inc [STJ] is traded on New York Stock Exchange in USA. It is located in Saint Paul, MN and employs 15,000 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
STJ United States NYSE
St Jude Medical Inc
Benchmark S&P 500
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
    
Chance of
Bankruptcy
Less
Than
39%
In The Next
Two Years
St Jude Medical Inc has less than 39.38 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

St Jude price boundaries

    
May 02 2013
 40.92 
  
 40.68 
(0.24)  Macroaxis: -0.5865102639296236 Down   0.59%  
Lowest period price (30 days)
May 17 2013
 46.84 
  
 47.00 
0.16  Macroaxis: 0.3415883859948689 Up   0.34%  
Highest period price (30 days)
    

Promote St Jude and Stuart Essig

Follow St Jude with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add St Jude to your reader
 

Today Change

 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States Russel   0.38 % Macroaxis: 0.38 Moved Down  
 
 United States SP 500   0.39 % Macroaxis: 0.39 Moved Down  
 
 thisRed STJ STJ agains markets  0.66 % Macroaxis: 0.66 Moved Down  
 
 United States NYSE   0.79 % Macroaxis: 0.79 Moved Down  
 

Stock Performance

Shares Outstanding283.36 M
Number of Shares Shorted10.25 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium